New stably transfected bioluminescent cells expressing FLAG epitope-tagged estrogen receptors to study their chromatin recruitment

BMC Biotechnology

Volumn 9, Issue , 2009, Pages 77-

  Badia, Eric ^a   Escande, Aurélie ^a   Balaguer, Patrick ^a   Métivier, Raphaël ^b   Cavailles, Vincent ^a  

^a INSTITUT DE RECHERCHE EN CANCÉROLOGIE DE MONTPELLIER   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ACTIONS; BIPHASIC; BIPHASIC BEHAVIOUR; CELL LINES; CELLULAR MODEL; CHIP EXPERIMENTS; COMPARATIVE EVALUATIONS; ESTROGEN RECEPTOR; ESTROGEN RESPONSE ELEMENTS; HELA CELL; HELA CELL LINE; IMMUNOPRECIPITATIONS; KINETIC EVALUATIONS; LUCIFERASE GENES; MCF-7 CELLS; POLYMERASE II; RELATIVE IMPORTANCE; TRANSCRIPTIONAL ACTIVATIONS; TRANSCRIPTIONAL ACTIVITY; TRANSCRIPTIONAL REGULATION;

ANTIBODIES; CELL CULTURE; DERIVATIVES; EMPLOYMENT; LAWS AND LEGISLATION; TRANSCRIPTION;

CELL MEMBRANES;

DNA DIRECTED DNA POLYMERASE ALPHA; EPITOPE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LUCIFERASE;

ARTICLE; CELL STIMULATION; CELL STRAIN MCF 7; CHEMICAL LABELING; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HELA CELL; HORMONE BINDING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIGAND BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

CELL LINE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; EPITOPES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; LUCIFERASES; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

EID: 70350089388     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-9-77     Document Type: Article

References (39)

1. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M, Gustafsson JA. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997, 82(12):4258-4265. 10.1210/jc.82.12.4258, 9398750.
2. Menasce LP, White GR, Harrison CJ, Boyle JM. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 1993, 17(1):263-265. 10.1006/geno.1993.1320, 8406468.
3. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996, 93(12):5925-5930. 10.1073/pnas.93.12.5925, 39164, 8650195.
4. Zhao C, Dahlman-Wright K, Gustafsson J. Estrogen receptor β: an overview and update. Nuclear Receptor Signaling 2008, 6:1-10.
5. Harris HA. Estrogen receptor-beta: recent lessons from in vivo studies. Mol Endocrinol 2007, 21(1):1-13. 10.1210/me.2005-0459, 16556737.
6. Koehler KF, Helguero LA, Haldosen LA, Warner M, Gustafsson JA. Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev 2005, 26(3):465-478. 10.1210/er.2004-0027, 15857973.
7. Pettersson K, Gustafsson JA. Role of estrogen receptor beta in estrogen action. Annu Rev Physiol 2001, 63:165-192. 10.1146/annurev.physiol.63.1.165, 11181953.
8. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 2003, 3(5):281-292. 10.1124/mi.3.5.281, 14993442.
9. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y, Muramatsu M. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res 1998, 26(15):3505-3512. 10.1093/nar/26.15.3505, 147730, 9671811.
10. Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lupu R. Expression of estrogen receptor beta messenger RNA variant in breast cancer. Cancer Res 1998, 58(2):210-214.
11. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM, Willson TM. Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 1998, 247(1):75-78. 10.1006/bbrc.1998.8738, 9636657.
12. Xu L, Pan-Hammarstrom Q, Forsti A, Hemminki K, Hammarstrom L, Labuda D, Gustafsson JA, Dahlman-Wright K. Human estrogen receptor beta 548 is not a common variant in three distinct populations. Endocrinology 2003, 144(8):3541-3546. 10.1210/en.2002-0118, 12865336.
13. Forster C, Makela S, Warri A, Kietz S, Becker D, Hultenby K, Warner M, Gustafsson JA. Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA 2002, 99(24):15578-15583. 10.1073/pnas.192561299, 137759, 12438700.
14. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price RH, Pestell RG, Kushner PJ. Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression. J Biol Chem 2002, 277(27):24353-24360. 10.1074/jbc.M201829200, 11986316.
15. Metivier R, Reid G, Gannon F. Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. EMBO Rep 2006, 7(2):161-167. 10.1038/sj.embor.7400626, 1369254, 16452926.
16. Burakov D, Crofts LA, Chang CP, Freedman LP. Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor. J Biol Chem 2002, 277(17):14359-14362. 10.1074/jbc.C200099200, 11893728.
17. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103(6):843-852. 10.1016/S0092-8674(00)00188-4, 11136970.
18. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 2003, 11(3):695-707. 10.1016/S1097-2765(03)00090-X, 12667452.
19. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003, 115(6):751-763. 10.1016/S0092-8674(03)00934-6, 14675539.
20. Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, Carmouche RP, Ibberson D, Barath P, Demay F, Reid G. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452(7183):45-50. 10.1038/nature06544, 18322525.
21. Lewandowski S, Kalita K, Kaczmarek L. Estrogen receptor beta. Potential functional significance of a variety of mRNA isoforms. FEBS Lett 2002, 524(1-3):1-5. 10.1016/S0014-5793(02)03015-6, 12135731.
22. Liu Y, Gao H, Marstrand TT, Strom A, Valen E, Sandelin A, Gustafsson JA, Dahlman-Wright K. The genome landscape of ERalpha- and ERbeta-binding DNA regions. Proc Natl Acad Sci USA 2008, 105(7):2604-2609. 10.1073/pnas.0712085105, 2268183, 18272478.
23. Matthews J, Wihlen B, Tujague M, Wan J, Strom A, Gustafsson JA. Estrogen receptor (ER) beta modulates ERalpha-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol Endocrinol 2006, 20(3):534-543. 10.1210/me.2005-0140, 16293641.
24. Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J Mol Endocrinol 2005, 34(2):553-566. 10.1677/jme.1.01688, 15821116.
25. Secreto FJ, Monroe DG, Dutta S, Ingle JN, Spelsberg TC. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells. J Cell Biochem 2007, 101(5):1125-1147. 10.1002/jcb.21205, 17520659.
26. Balaguer P, Francois F, Comunale F, Fenet H, Boussioux AM, Pons M, Nicolas JC, Casellas C. Reporter cell lines to study the estrogenic effects of xenoestrogens. Sci Total Environ 1999, 233(1-3):47-56. 10.1016/S0048-9697(99)00178-3, 10492897.
27. Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavailles V, Balaguer P. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem Pharmacol 2006, 71(10):1459-1469. 10.1016/j.bcp.2006.02.002, 16554039.
28. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 2001, 44(24):4230-4251. 10.1021/jm010254a, 11708925.
29. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem 2000, 43(26):4934-4947. 10.1021/jm000170m, 11150164.
30. George AA, Schiltz RL, Hager GL. Dynamic access of the glucocorticoid receptor to response elements in chromatin. Int J Biochem Cell Biol 2009, 41(1):214-224. 10.1016/j.biocel.2008.09.019, 18930837.
31. Subramanian K, Jia D, Kapoor-Vazirani P, Powell DR, Collins RE, Sharma D, Peng J, Cheng X, Vertino PM. Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell 2008, 30(3):336-347. 10.1016/j.molcel.2008.03.022, 2567917, 18471979.
32. Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP, Benes V, Gannon F, Reid G. Transient cyclical methylation of promoter DNA. Nature 2008, 452(7183):112-115. 10.1038/nature06640, 18322535.
33. Hu P, Kinyamu KH, Wang L, Martin J, Archer TK, Teng CT. Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells. Biol Chem 2008, 283(11):6752-6763.
34. Lonard DM, Nawaz Z, Smith CL, O'Malley BW. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol Cell 2000, 5(6):939-948. 10.1016/S1097-2765(00)80259-2, 10911988.
35. Fowler AM, Solodin NM, Valley CC, Alarid ET. Altered target gene regulation controlled by estrogen receptor-alpha concentration. Mol Endocrinol 2006, 20(2):291-301. 10.1210/me.2005-0288, 16179380.
36. Park S, Song J, Joe CO, Shin I. Akt stabilizes estrogen receptor alpha with the concomitant reduction in its transcriptional activity. Cell Signal 2008, 20(7):1368-1374. 10.1016/j.cellsig.2008.03.004, 18450422.
37. Duong V, Boulle N, Daujat S, Chauvet J, Bonnet S, Neel H, Cavailles V. Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents. Cancer Res 2007, 67(11):5513-5521. 10.1158/0008-5472.CAN-07-0967, 17545634.
38. Zhao C, Matthews J, Tujague M, Wan J, Strom A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res 2007, 67(8):3955-3962. 10.1158/0008-5472.CAN-06-3505, 17440111.
39. Hodges-Gallagher L, Valentine CD, El Bader S, Kushner PJ. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Breast Cancer Res Treat 2008, 109(2):241-250. 10.1007/s10549-007-9640-6, 17638070.